Search research articles
Contact Us
Filters
Showing results (61-70 of 155) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group
Steven H Bernstein, Joseph M Unger, Michael Leblanc, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
December 22, 2004
FDG-PET prediction of head and neck squamous cell cancer outcomes
David L Schwartz, Joseph Rajendran, Bevan Yueh, et al.
JAMA Network Open
|
September 5, 2019
Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
Joseph M Unger, Van T Nghiem, Dawn L Hershman, et al.
The American Journal of Surgical Pathology
|
March 15, 2014
Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study
James R Cook, Bryan Goldman, Raymond R Tubbs, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 13, 2018
Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride
James Y Dai, Michael LeBlanc, Phyllis J Goodman, et al.
JAMA Oncology
|
March 12, 2016
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials
Joseph M Unger, William E Barlow, Scott D Ramsey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2005
New treatment options have changed the survival of patients with follicular lymphoma
Richard I Fisher, Michael LeBlanc, Oliver W Press, et al.
The Canadian Journal of Hospital Pharmacy
|
July 8, 2026
Leadership and Managerial Development Needs of Pharmacy Leaders in Canadian Health Care Systems: Results from a National Questionnaire
Heather Naylor, Wooje Choi, Michael LeBlanc, et al.
JAMA Oncology
|
February 26, 2026
Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial
Mazyar Shadman, Michael LeBlanc, Lisa Rimsza, et al.
JAMA Network Open
|
May 1, 2020
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
Joseph M Unger, Charles D Blanke, Michael LeBlanc, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 155) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group
Steven H Bernstein, Joseph M Unger, Michael Leblanc, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
December 22, 2004
FDG-PET prediction of head and neck squamous cell cancer outcomes
David L Schwartz, Joseph Rajendran, Bevan Yueh, et al.
JAMA Network Open
|
September 5, 2019
Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
Joseph M Unger, Van T Nghiem, Dawn L Hershman, et al.
The American Journal of Surgical Pathology
|
March 15, 2014
Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study
James R Cook, Bryan Goldman, Raymond R Tubbs, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 13, 2018
Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride
James Y Dai, Michael LeBlanc, Phyllis J Goodman, et al.
JAMA Oncology
|
March 12, 2016
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials
Joseph M Unger, William E Barlow, Scott D Ramsey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2005
New treatment options have changed the survival of patients with follicular lymphoma
Richard I Fisher, Michael LeBlanc, Oliver W Press, et al.
The Canadian Journal of Hospital Pharmacy
|
July 8, 2026
Leadership and Managerial Development Needs of Pharmacy Leaders in Canadian Health Care Systems: Results from a National Questionnaire
Heather Naylor, Wooje Choi, Michael LeBlanc, et al.
JAMA Oncology
|
February 26, 2026
Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial
Mazyar Shadman, Michael LeBlanc, Lisa Rimsza, et al.
JAMA Network Open
|
May 1, 2020
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
Joseph M Unger, Charles D Blanke, Michael LeBlanc, et al.
Page
of 16